Piramal Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep' 24	Jun' 24	Mar' 24	Dec' 23	Sep' 23

Sales

1,284.39

1,063.20

1,525.30

1,024.14

994.24

Operating profit

252.89

151.63

389.64

125.53

86.16

Interest

29.95

24.88

27.66

17.42

28.22

Gross profit

329.32

163.51

415.17

141.22

147.02

EPS (Rs)

1.59

0.64

2.06

0.56

0.58

Other income

106.38

36.76

53.19

33.11

89.08

Stock adjustment

-71.41

-132.35

135.74

-120.72

-11.59

Raw material

380.22

405.76

417.52

444.94

356.76

Power and fuel

-

-

-

-

-

Employee expenses

176.72

186.96

152.88

150.56

151.44

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

545.97

451.20

429.52

423.83

411.47

Provisions made

-

-

-

-

-

Depreciation

53.61

51.85

52.50

51.56

50.83

Taxation

65.65

26.39

89.59

15.32

19.03

Net profit / loss

210.06

85.27

273.08

74.34

77.16

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

1,323.14

1,322.95

1,322.95

1,322.95

1,322.95

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

19.69

14.26

25.55

12.26

8.67

GPM (%)

23.68

14.87

26.30

13.36

13.57

NPM (%)

15.10

7.75

17.30

7.03

7.12